Physicians integrate both general-purpose and clinical AI into daily workflows, increasing pressure on pharma brands to tailor drug content for the distinct requirements and outputs of each AI ecosystem.

More than half (53%) of US physicians plan to significantly increase AI use over the next year, per a DHC Group and Sermo study in November. As physicians increasingly rely on AI for support, the information they encounter will be shaped by the quality of the science-based content that AI systems will surface.